- Home
- AEVA vs CRMD Comparison
AEVA vs CRMD Comparison
Compare AEVA & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEVA
- CRMD
- Stock Information
- Founded
- AEVA 2019
- CRMD 2006
- Country
- AEVA United States
- CRMD United States
- Employees
- AEVA N/A
- CRMD N/A
- Industry
- AEVA Auto Parts:O.E.M.
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- AEVA Consumer Discretionary
- CRMD Health Care
- Exchange
- AEVA Nasdaq
- CRMD Nasdaq
- Market Cap
- AEVA 394.4M
- CRMD 464.7M
- IPO Year
- AEVA N/A
- CRMD 2010
- Fundamental
- Price
- AEVA $11.12
- CRMD $11.66
- Analyst Decision
- AEVA Buy
- CRMD Strong Buy
- Analyst Count
- AEVA 6
- CRMD 6
- Target Price
- AEVA $7.14
- CRMD $15.00
- AVG Volume (30 Days)
- AEVA 1.4M
- CRMD 2.2M
- Earning Date
- AEVA 05-14-2025
- CRMD 05-06-2025
- Dividend Yield
- AEVA N/A
- CRMD N/A
- EPS Growth
- AEVA N/A
- CRMD N/A
- EPS
- AEVA N/A
- CRMD 0.28
- Revenue
- AEVA $9,065,000.00
- CRMD $82,553,827.00
- Revenue This Year
- AEVA $76.83
- CRMD $207.65
- Revenue Next Year
- AEVA $187.14
- CRMD $50.13
- P/E Ratio
- AEVA N/A
- CRMD $42.08
- Revenue Growth
- AEVA 110.23
- CRMD N/A
- 52 Week Low
- AEVA $2.20
- CRMD $3.61
- 52 Week High
- AEVA $10.74
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- AEVA 78.81
- CRMD 71.85
- Support Level
- AEVA $6.86
- CRMD $8.72
- Resistance Level
- AEVA $9.53
- CRMD $9.82
- Average True Range (ATR)
- AEVA 0.75
- CRMD 0.67
- MACD
- AEVA 0.30
- CRMD 0.40
- Stochastic Oscillator
- AEVA 100.00
- CRMD 84.78
About AEVA Aeva Technologies Inc.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.